Why Ultragenyx Pharmaceutical Stock Is Cratering Today
Shares of the rare disease specialist Ultragenyx Pharmaceutical (NASDAQ: RARE) are having a rough session Tuesday. Specifically, the biotech's stock dropped by as much as 17% in early morning action.
The company's shares have rebounded to some degree since, but Ultragenyx's stock was still down by a hefty 13% as of 11:30 a.m. ET.
Image Source: Getty Images.
Source Fool.com
